Bibliometric Analysis of Immune-Related Adverse Events in Lung Cancer, 2016–2025

1,792 eligible records from the Web of Science Core Collection form the basis of this bibliometric analysis of immune-related adverse events (irAEs) in lung cancer treated with immune checkpoint inhibitors. The dataset, created by Bing Guo and shared under a CC-BY-4.0 license, includes publication trends, country-level contributions, and keyword evolution from 2016 to 2025. Supplementary mapping from PubMed clinical studies adds context on study types and intervention regimens.

Use Cases

• Analyzing publication trends and research phase evolution based on annual publication volume from 2016 to 2025.
• Mapping international collaboration patterns based on country publication counts and betweenness centrality metrics.
• Identifying research hotspots and topic migration based on keyword burst analysis and co-citation clusters.
• Supplementing clinical study mapping based on PubMed records categorized by study type, disease setting, and intervention regimen.

Strengths

• Includes 1,792 eligible bibliographic records from the Web of Science Core Collection.
• Covers a defined 10-year time range from 2016 to 2025.
• Provides supplementary mapping from PubMed clinical studies for context.
• Released under a permissive CC-BY-4.0 license.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• The dataset is very small at 22.9 KB, indicating limited scope and likely summary-level data.
• Data may reflect the geographic and source bias inherent to the Web of Science and PubMed databases.

Provenance

Source

Web of Science Core Collection and PubMed databases.

Collection Method

Bibliometric and visualization analysis conducted using Bibliometrix and CiteSpace tools.

Time Range

2016 to 2025

Freshness

Last updated 2026-06-02 05:40:29; freshness should be verified.

Geography

Global, with specific mention of China and the United States.